Steatohepatitis/Metabolic Liver Disease

Top Story

Intragastric balloon for fatty liver intervention does not affect gut microflora

April 18, 2018
Meeting NewsVideo

Givosiran reduces neurotoxic intermediates in acute hepatic porphyria

April 17, 2018
PARIS — Givosiran, an investigational RNA interference therapeutic, was generally well-tolerated and reduced aminolevulinic acid and porphobilinogen accumulation…
Meeting News

Growth factor improved fatty liver score in 84% of patients

April 16, 2018
PARIS — Patients who received NGM282, a novel growth factor, showed improved noninvasive markers of nonalcoholic steatohepatitis and a histologic response after 12…
Meeting News

Galectin-3 inhibitor improves hepatic ballooning in NASH

April 14, 2018
PARIS — GR-MD-02, a novel galectin-3 protein, did not improve hepatic venous pressure gradient in patients with nonalcoholic steatohepatitis and cirrhosis;…
More Headlines »